SILICON LABORATORIES INC (SLAB) Fundamental Analysis & Valuation

NASDAQ:SLAB • US8269191024

Current stock price

203 USD
+0.93 (+0.46%)
At close:
203 USD
0 (0%)
After Hours:

This SLAB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. SLAB Profitability Analysis

1.1 Basic Checks

  • SLAB had positive earnings in the past year.
  • In the past year SLAB had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: SLAB reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: SLAB reported negative operating cash flow in multiple years.
SLAB Yearly Net Income VS EBIT VS OCF VS FCFSLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

1.2 Ratios

  • SLAB has a Return On Assets of -5.11%. This is in the lower half of the industry: SLAB underperforms 62.61% of its industry peers.
  • SLAB's Return On Equity of -5.93% is on the low side compared to the rest of the industry. SLAB is outperformed by 61.74% of its industry peers.
Industry RankSector Rank
ROA -5.11%
ROE -5.93%
ROIC N/A
ROA(3y)-7.71%
ROA(5y)10.53%
ROE(3y)-8.82%
ROE(5y)15.15%
ROIC(3y)N/A
ROIC(5y)N/A
SLAB Yearly ROA, ROE, ROICSLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

1.3 Margins

  • SLAB's Gross Margin of 58.23% is amongst the best of the industry. SLAB outperforms 83.48% of its industry peers.
  • SLAB's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for SLAB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.46%
GM growth 5Y0.18%
SLAB Yearly Profit, Operating, Gross MarginsSLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200

8

2. SLAB Health Analysis

2.1 Basic Checks

  • SLAB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SLAB has been increased compared to 1 year ago.
  • SLAB has less shares outstanding than it did 5 years ago.
  • SLAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SLAB Yearly Shares OutstandingSLAB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
SLAB Yearly Total Debt VS Total AssetsSLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • SLAB has an Altman-Z score of 24.92. This indicates that SLAB is financially healthy and has little risk of bankruptcy at the moment.
  • SLAB has a better Altman-Z score (24.92) than 88.70% of its industry peers.
  • There is no outstanding debt for SLAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 24.92
ROIC/WACCN/A
WACC11.48%
SLAB Yearly LT Debt VS Equity VS FCFSLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 4.69 indicates that SLAB has no problem at all paying its short term obligations.
  • SLAB has a Current ratio of 4.69. This is in the better half of the industry: SLAB outperforms 68.70% of its industry peers.
  • A Quick Ratio of 4.02 indicates that SLAB has no problem at all paying its short term obligations.
  • SLAB has a Quick ratio of 4.02. This is in the better half of the industry: SLAB outperforms 71.30% of its industry peers.
Industry RankSector Rank
Current Ratio 4.69
Quick Ratio 4.02
SLAB Yearly Current Assets VS Current LiabilitesSLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

8

3. SLAB Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 152.91% over the past year.
  • Measured over the past years, SLAB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.23% on average per year.
  • Looking at the last year, SLAB shows a very strong growth in Revenue. The Revenue has grown by 34.29%.
  • SLAB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.96% yearly.
EPS 1Y (TTM)152.91%
EPS 3Y-42.31%
EPS 5Y-21.23%
EPS Q2Q%609.09%
Revenue 1Y (TTM)34.29%
Revenue growth 3Y-8.49%
Revenue growth 5Y8.96%
Sales Q2Q%25.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 70.47% on average over the next years. This is a very strong growth
  • SLAB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.81% yearly.
EPS Next Y204.7%
EPS Next 2Y115.53%
EPS Next 3Y70.47%
EPS Next 5YN/A
Revenue Next Year18.24%
Revenue Next 2Y17.44%
Revenue Next 3Y15.81%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SLAB Yearly Revenue VS EstimatesSLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
SLAB Yearly EPS VS EstimatesSLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

2

4. SLAB Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 223.08, SLAB can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of SLAB is on the same level as its industry peers.
  • SLAB's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.70.
  • Based on the Price/Forward Earnings ratio of 73.21, the valuation of SLAB can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SLAB indicates a slightly more expensive valuation: SLAB is more expensive than 60.87% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. SLAB is valued rather expensively when compared to this.
Industry RankSector Rank
PE 223.08
Fwd PE 73.21
SLAB Price Earnings VS Forward Price EarningsSLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

  • SLAB's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 101.71
EV/EBITDA N/A
SLAB Per share dataSLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • SLAB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • SLAB's earnings are expected to grow with 70.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.09
PEG (5Y)N/A
EPS Next 2Y115.53%
EPS Next 3Y70.47%

0

5. SLAB Dividend Analysis

5.1 Amount

  • SLAB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SLAB Fundamentals: All Metrics, Ratios and Statistics

SILICON LABORATORIES INC

NASDAQ:SLAB (3/13/2026, 8:00:02 PM)

After market: 203 0 (0%)

203

+0.93 (+0.46%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-04
Earnings (Next)05-11
Inst Owners102.77%
Inst Owner Change0.61%
Ins Owners2.03%
Ins Owner Change1.81%
Market Cap6.69B
Revenue(TTM)784.76M
Net Income(TTM)-64.91M
Analysts68.89
Price Target219.88 (8.32%)
Short Float %4.97%
Short Ratio2.15
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.16%
Min EPS beat(2)0.17%
Max EPS beat(2)2.15%
EPS beat(4)4
Avg EPS beat(4)7.94%
Min EPS beat(4)0.17%
Max EPS beat(4)16.59%
EPS beat(8)7
Avg EPS beat(8)11.43%
EPS beat(12)8
Avg EPS beat(12)8.98%
EPS beat(16)12
Avg EPS beat(16)14.53%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-1.66%
Max Revenue beat(2)-1.66%
Revenue beat(4)0
Avg Revenue beat(4)-1.74%
Min Revenue beat(4)-1.84%
Max Revenue beat(4)-1.66%
Revenue beat(8)1
Avg Revenue beat(8)-1.15%
Revenue beat(12)1
Avg Revenue beat(12)-1.08%
Revenue beat(16)4
Avg Revenue beat(16)-0.59%
PT rev (1m)41.64%
PT rev (3m)42.45%
EPS NQ rev (1m)2.54%
EPS NQ rev (3m)0.8%
EPS NY rev (1m)0.48%
EPS NY rev (3m)1.06%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)0.7%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)0.56%
Valuation
Industry RankSector Rank
PE 223.08
Fwd PE 73.21
P/S 8.53
P/FCF 101.71
P/OCF 69.91
P/B 6.11
P/tB 9.63
EV/EBITDA N/A
EPS(TTM)0.91
EY0.45%
EPS(NY)2.77
Fwd EY1.37%
FCF(TTM)2
FCFY0.98%
OCF(TTM)2.9
OCFY1.43%
SpS23.81
BVpS33.2
TBVpS21.08
PEG (NY)1.09
PEG (5Y)N/A
Graham Number26.07
Profitability
Industry RankSector Rank
ROA -5.11%
ROE -5.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.23%
FCFM 8.38%
ROA(3y)-7.71%
ROA(5y)10.53%
ROE(3y)-8.82%
ROE(5y)15.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.46%
GM growth 5Y0.18%
F-Score6
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 78.57%
Cap/Sales 3.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.69
Quick Ratio 4.02
Altman-Z 24.92
F-Score6
WACC11.48%
ROIC/WACCN/A
Cap/Depr(3y)48.79%
Cap/Depr(5y)47.77%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.91%
EPS 3Y-42.31%
EPS 5Y-21.23%
EPS Q2Q%609.09%
EPS Next Y204.7%
EPS Next 2Y115.53%
EPS Next 3Y70.47%
EPS Next 5YN/A
Revenue 1Y (TTM)34.29%
Revenue growth 3Y-8.49%
Revenue growth 5Y8.96%
Sales Q2Q%25.24%
Revenue Next Year18.24%
Revenue Next 2Y17.44%
Revenue Next 3Y15.81%
Revenue Next 5YN/A
EBIT growth 1Y57.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year452.96%
EBIT Next 3Y99.57%
EBIT Next 5YN/A
FCF growth 1Y356.4%
FCF growth 3Y13.24%
FCF growth 5Y-10.97%
OCF growth 1Y788.05%
OCF growth 3Y10.05%
OCF growth 5Y-6.74%

SILICON LABORATORIES INC / SLAB Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SILICON LABORATORIES INC (SLAB) stock?

ChartMill assigns a fundamental rating of 5 / 10 to SLAB.


What is the valuation status for SLAB stock?

ChartMill assigns a valuation rating of 2 / 10 to SILICON LABORATORIES INC (SLAB). This can be considered as Overvalued.


What is the profitability of SLAB stock?

SILICON LABORATORIES INC (SLAB) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for SLAB stock?

The Price/Earnings (PE) ratio for SILICON LABORATORIES INC (SLAB) is 223.08 and the Price/Book (PB) ratio is 6.11.


How financially healthy is SILICON LABORATORIES INC?

The financial health rating of SILICON LABORATORIES INC (SLAB) is 8 / 10.